MGMT and central nervous system cancer: We assessed the impact of ionizing radiation (2 Gy) on the intracellular delivery of 3′-carboxyfluorescein labeled nonspecific f-ON administered 1 day after radiation in MGMT-expressing T98G glioma cells in vitro.